MEDANTA — Global Health Balance Sheet
0.000.00%
- IN₹318.63bn
- IN₹314.27bn
- IN₹36.92bn
Annual balance sheet for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,211 | 5,634 | 12,781 | 11,753 | 11,551 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,339 | 1,804 | 2,235 | 2,470 | 2,919 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,021 | 8,117 | 15,795 | 15,087 | 15,331 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 20,722 | 22,088 | 23,719 | 26,179 | 30,361 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 26,941 | 31,455 | 41,160 | 43,041 | 47,662 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,047 | 4,195 | 5,726 | 6,177 | 6,188 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 13,118 | 15,295 | 16,878 | 13,984 | 13,798 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 13,823 | 16,160 | 24,282 | 29,056 | 33,864 |
Total Liabilities & Shareholders' Equity | 26,941 | 31,455 | 41,160 | 43,041 | 47,662 |
Total Common Shares Outstanding |